{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:12Z","timestamp":1786985472817,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.braindev.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T21:41:28Z","timestamp":1643751688000},"page":"319-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome"],"prefix":"10.1016","volume":"44","author":[{"given":"Kenjiro","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuki","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazuki","family":"Nonoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Daida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Koichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2022.01.004_b0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.seizure.2016.10.014","article-title":"From genotype to phenotype in Dravet disease","volume":"44","author":"Gataullina","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2022.01.004_b0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2017.01.025","article-title":"Optimizing the diagnosis and management of Dravet syndrome: recommendations from a North American Consensus Panel","volume":"68","author":"Wirrell","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0015","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1111\/epi.16334","article-title":"Dravet syndrome: treatment options and management of prolonged seizures","volume":"60","author":"Cross","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1528-1167.2009.02466.x","article-title":"A long-term follow-up study of Dravet syndrome up to adulthood","volume":"51","author":"Akiyama","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0025","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/epi.12532","article-title":"Long-term course of Dravet syndrome: a study from an epilepsy center in Japan","volume":"55","author":"Takayama","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"10.1016\/j.braindev.2022.01.004_b0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1528-1167.2011.03001.x","article-title":"Dravet syndrome: the long-term outcome","volume":"52","author":"Genton","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0035","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ejpn.2012.04.007","article-title":"Diagnosis and long-term course of Dravet syndrome","volume":"16","author":"Scheffer","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eplepsyres.2016.10.006","article-title":"Mortality in Dravet syndrome","volume":"128","author":"Cooper","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2022.01.004_b0045","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1017\/cjn.2016.243","article-title":"Dravet syndrome: diagnosis and long-term course","volume":"43","author":"Connolly","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.braindev.2022.01.004_b0050","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increase the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci"},{"issue":"Suppl 5","key":"10.1016\/j.braindev.2022.01.004_b0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1528-1167.2007.01297.x","article-title":"GABA(A) receptor internalization during seizures","volume":"48","author":"Goodkin","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.braindev.2022.01.004_b0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1474-4422(08)70141-8","article-title":"Treatment of community-onset, childhood convulsive status epilepticus: a prospective, population-based study","volume":"7","author":"Chin","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.seizure.2016.11.001","article-title":"25 years of advances in the definition, classification and treatment of status epilepticus","volume":"44","author":"Trinka","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2022.01.004_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1528-1167.2011.03311.x","article-title":"Acute encephalopaty in children with Dravet syndrome","volume":"53","author":"Okumura","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0080","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus -Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0085","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/epi.13639","article-title":"Clinical implications of SCN1A missense and truncation variants in a large Japanese cohort with Dravet syndrome","volume":"58","author":"Ishii","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eplepsyres.2011.10.010","article-title":"Early clinical features in Dravet syndrome patients with and without SCN1A mutations","volume":"99","author":"Petrelli","year":"2012","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.braindev.2022.01.004_b0095","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1093\/brain\/aws151","article-title":"Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome","volume":"135","author":"Brunklaus","year":"2012","journal-title":"Brain"},{"issue":"S3","key":"10.1016\/j.braindev.2022.01.004_b0100","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/epi.16386","article-title":"SCN1A-related phenotypes: epilepsy and beyond","volume":"60","author":"Scheffer","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.braindev.2008.03.002","article-title":"Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) -a nationwide questionnaire survey in Japan","volume":"30","author":"Tanabe","year":"2008","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2022.01.004_b0110","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.seizure.2010.01.007","article-title":"Unusual consequences of status epilepticus in Dravet syndrome","volume":"19","author":"Chipaux","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.braindev.2022.01.004_b0115","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pediatrneurol.2007.02.012","article-title":"Efficacy of intravenous midazolam for status epilepticus in childhood","volume":"36","author":"Hayashi","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0120","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/0883073816638757","article-title":"A comparison of midazolam, lorazepam, and diazepam for the treatment of status epilepticus in children: a network meta-analysis","volume":"31","author":"Zhao","year":"2016","journal-title":"J Child Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0125","doi-asserted-by":"crossref","unstructured":"McTague A, Martland T, Appleton R. Drugs management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2018;1:CD001905.","DOI":"10.1002\/14651858.CD001905.pub3"},{"key":"10.1016\/j.braindev.2022.01.004_b0130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2018.09.035","article-title":"Efficacy, safety, and pharmacokinetics of intravenous midazolam in Japanese children with status epilepticus","volume":"396","author":"Hamano","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.braindev.2022.01.004_b0135","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1933","article-title":"Fatal cerebral edema with status epilepticus in children with Dravet syndrome: report of 5 cases","volume":"139","author":"Myers","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.braindev.2022.01.004_b0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/dmcn.13727","article-title":"The clinical outcome and neuroimaging of acute encephalopathy after status epilepticus in Dravet syndrome","volume":"60","author":"Tian","year":"2018","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0145","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1528-1167.2011.03402.x","article-title":"Mutation of the SCN1A gene in acute encephalopathy","volume":"53","author":"Saitoh","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0150","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/j.1528-1167.2009.02179.x","article-title":"Stiripentol open study in Japanese patients with Dravet syndrome","volume":"50","author":"Inoue","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0155","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(19)32500-0","article-title":"Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial","volume":"394","author":"Lagae","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.braindev.2022.01.004_b0160","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/epi.16474","article-title":"Successful use of fenfluramine in nonconvulsive status epilepticus of Dravet syndrome","volume":"61","author":"Specchio","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.braindev.2022.01.004_b0165","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/jamaneurol.2019.4113","article-title":"Fenfluramine for treatment -resistant seizures in patients with Dravet syndrome receiving stiripentol-inclusive regimens","volume":"77","author":"Nabbout","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0170","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.braindev.2022.01.004_b0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaneurol.2020.0073","article-title":"Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in Dravet syndrome: a randomized clinical trial","volume":"775","author":"Miller","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.braindev.2022.01.004_b0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pediatrneurol.2020.01.005","article-title":"Dravet syndrome: a review of current management","volume":"107","author":"Wheless","year":"2020","journal-title":"Pediatr Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760422000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760422000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:50:28Z","timestamp":1759953028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760422000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0387760422000067"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2022.01.004","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society of Child Neurology Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}